You are here

Home » Content

Çok düşük doğum ağırlıklı bebeklerde total parenteral beslenme ilişkili kolestaz ve ursodeoksikolik asit tedavisinin etkinliği

Total parenteral nutrition-associated cholestasis and the effect of ursodeoxycholic acid in very low birth weight infants

Journal Name:

  • Süleyman Demirel Üniversitesi Tıp Fakültesi Dergisi

Publication Year:

  • 2006

Key Words:

Keywords (Original Language):

Author NameUniversity of AuthorFaculty of Author
Abstract (2. Language): 
Prolonged parenteral nutrition are necessary and there is high risk of cholestasis in very low birth weight infants. The aim of this study was to determine the rate of cholestasis, correlation with enteral feeding and the effect of ursodeoxycholic acid in very low birth weight infants. The data of five years in Neonatal Intensive Care Unit belong to very low birth weight infants was analysed. In the second half of the performed study, minimal enteral feeding was started by the dose of 15-20 ml/kg/day when the gastointestinal system was ready to feeding. Although total parenteral nutrition days was longer, the age of minimal enteral feeding significantly shorter in second period than first period(p<0.05). Total cholestasis rate was detected as 12%. The rate of cholestasis significantly reduced from 20.8% to 5% in second period(p<0.05). Ursodeoxycholic acid treatment shortened the period of cholestasis significantly. In conclusion enteral feeding should be begin quickly. The use of ursodeoxycholic acid treatment could be beneficial in the treatment of total parenteral nutrition associated cholestasis.
Bookmark/Search this post with
Abstract (Original Language): 
Çok düşük doğum ağırlıklı bebeklerde uzun süreli parenteral beslenme gereklidir ve kolestaz riski de fazladır. Çalışmanın amacı çok düşük doğum ağırlığı olan bebeklerde kolestaz oranını, enteral beslenmeyle olan ilişkisini belirlemek, ursodeoksikolik asid tedavisinin etkisini değerlendirmektir. Yenidoğan Yoğun Bakım Ünitesinde çok düşük doğum ağırlıklı bebeklere ait beş yıllık veriler değerlendirildi. Çalışmanın ikinci yarısında gastrointestinal sistem beslenmeye elverişli hale gelince 15-20 ml/kg/gün olacak şekilde minimal enteral beslenme başlandı. İkinci dönemde total parenteral beslenme süresi uzun olmasına rağmen minimal enteral beslemeye başlama zamanı anlamlı olarak kısa idi(p<0.05). Total kolestaz oranı %12 saptandı. Kolestaz oranının ikinci dönemde belirgin olarak %20.8'den %5'e gerilediği gözlendi(p<0.05). Ursodeoksikolik asid tedavisiyle kolestaz süresinin belirgin oranda kısaldığı gözlendi. Sonuç olarak enteral beslenme olabildiğince çabuk başlanmalıdır. total parenteral beslenme ilişkili kolestaz tedavisinde ursodeoksikolik asid kullanımı faydalı olabilir.
FULL TEXT (PDF): 
PDF icon arastirmax-cok-dusuk-dogum-agirlikli-bebeklerde-total-parenteral-beslenme-iliskili-kolestaz-ursodeoksikolik-asit-tedavisinin-etkinligi.pdf
  • 4
7-11
  • Turkish

REFERENCES

References: 

1. Bell RL, Ferry GD, Smith EO, Shulman RJ, Christensen BL, Labarthe DR, et al. Total parenteral nutrition-related cholestasis in infants. 1986;10:356-9.
2. Sokol RJ. Total parenteral nutrition-related liver disease. Acta Pediatrica Taiwanica 1997;38:418-28.
3. Drongowski RA, Coran AG. An analysis of factors contributing to the development oftotal parenteral nutrition-induced cholestasis. 1989;13:586-9.
4. Btaiche IF, Khalidi N. Parenteral nutrition-associated liver complications in children. 2002;22:188-211.
5. Teitelbaum DH. Parenteral nutrition-associated cholestasis. 1997;9:270-5.
6. Sitzmann JV, Pitt HA, Steinborn PA, Pasha ZR, Sanders RC. Cholecystokinin prevents parenteral nutrition induced biliary sludge in humans. 1990;170:25-31.
7. Bowyer BA, Fleming CR, Ludwig J, Petz J, McGill DB. Does long-term home parenteral nutrition in adult patients cause chronic liver disease. 1985;9:11-7.
8. Stanko RT, Nathan G, Mendelow H, Adibi SA. Development ofhepatic cholestasis and fibrosis in patients with massive loss ofintestine supported by prolonged parenteral nutrition. 1987;92:197-202.
9. Levine A, Maayan A, Shamir R, Dinari G, Sulkes J, Sirotta L. Parenteral nutrition-associated cholestasis in preterm neonates: evaluation ofursodeoxycholic acidtreatment. 1999;12:549-53.
10. Kumar D, Tandon RK. Use ofursodeoxycholic acid inliverdiseases. 2001;16:3-14.
11. Quigley EM, Marsh MN, Shaffer JL, Markin RS. Hepatobiliary complications oftotal parenteral nutrition. 1993;104:286-301.
12. Hofmann AF. Defective biliary secretion during total parenteral nutrition: probable mechanisms and possible solutions. 1995;20:376-90.
13. Dahms BB, Halpin TC Jr. Serial liver biopsies in parenteral nutrition-associated cholestasis of early infancy. 1981;81:136-44.
14. Kubota A, Yonekura T,Hoki M, Oyanagi H, Kawahara H, Yagi M, et al. Total parenteral nutrition-associated intrahepatic cholestasis in infants: 25 years' experience. 2000;35:1049-51.
15. Brown MR, Thunberg BJ, Golub L, Maniscalco WM, Cox C, Shapiro DL. Decreased cholestasis with enteral instead ofintravenous protein in the very low-birth-weightinfant. 1989;9:21-7.
16. Angulo P, Batts KP, Therneau TM, Jorgensen RA, Dickson ER, Lindor KD. Long-term ursodeoxycholic acid delays histological progression in primary biliary cirrhosis. 1999;29:644-7.
17. Al-Hathlol K, Al-Madani A, Al-Saif S, Abulaimoun B, Al-Tawil K, El-Demerdash A. Ursodeoxycholic acid therapy for intractable total parenteral nutrition-
S.D.Ü. Tıp pak.
Derg
. 2006:13(4)/7-11
Çetin, Prematüre bebeklerde TPB ilişkili kolestaz.
11
associated cholestasis in surgical very low birth weight infants. 2006;47:147-51.
18. Dinler G, Kocak N, Yuce A, Gurakan F, Ozen H. Ursodeoxycholic acid therapy in children with cholestatic liver disease. Turk J Pediatr 1999;41:91-
8.
19. Chen CY, Tsao PN, Chen HL, Chou HC, Hsieh WS, Chang MH. Ursodeoxycholic acid (UDCA) therapy in very-low-birth-weight infants with parenteral nutrition-associated cholestasis. 2004;145:317-21.
20. Sokol RJ, Winklhofer-Roob BM, Devereaux MW, McKim JM Jr. Generation ofhydroperoxides in isolated rat hepatocytes and hepatic mitochondria exposed to hydrophobic bile acids. 1995;109:1249-56.
21. Orellana M, Rodrigo R, Thielemann L, Guajardo V. Bile duct ligation and oxidative stress in the rat: effects in liver and kidney. 2000;126:105-11.
22. Pemberton PW, Aboutwerat A, Smith A, Warnes TW. Ursodeoxycholic acid in primary biliary cirrhosis improves glutathione status but fails to reduce lipid peroxidation. 2006;11:117-23.

Thank you for copying data from http://www.arastirmax.com